agree. With the MCL deal just announced further endorsing that company's authenticity, AEB's prospects of delivering on its goals in partnership with MCL just got a whole lot better. Market should therefore mark AEB's value up accordingly in time.
I guess QBL was just a much more appealing play today in the pot space and drew the buying interest. And fair enough too...
Ann: QBL: MCL&AEB join to develop Cannabis veterinary medications, page-96
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
